McDermott Will & Emery advised MBO+ and the other shareholders of Groupe LT on the matter. The MBO+ continuation fund completed the acquisition of Groupe LT,...
MBO+’s Acquisition of Groupe LT
TreeFrog Therapeutics’ Licensing Agreement with Vertex
McDermott Will & Emery has advised TreeFrog Therapeutics on the deal. TreeFrog Therapeutics, a French biotech company aiming to unlock access to cell therapies for millions...
Galiena Capital’s Acquisition of a Stake in Topia Group
McDermott Will & Emery advised Galiena Capital on its investment. Galiena Capital has invested in the capital of Groupe Topia, a company specialized in landscaping and...
Group RG’s Acquisition of Vandeputte
McDermott advised Groupe RG on the acquisition. The RG Group has just reached a decisive milestone in its development strategy aimed at becoming the independent leader in the...
Aldebaran Capital Partners’ Acquisition of Numworks
McDermott Will & Emery advised Aldebaran Capital Partners on this transaction. DLA Piper advised a banking pool comprising Banque Populaire Rives de Paris, Caisse d’Epargne et...
Innate Pharma’s exclusive Licensing Agreement with Takeda
McDermott Will & Emery advised Innate Pharma S.A. in this transaction. Innate Pharma S.A., a clinical-stage biotechnology company specializing in the development of cancer immunotherapies, has...
Acquisition of Financière Canella in Secondary LBO by Five Arrows Sustainable Investments (FASI) and Andera Expansion 3
Racine advised Five Arrows Sustainable Investments. Andera and management were advised by McDermott Will & Emery. Five Arrows Sustainable Investments (FASI) recently completed a secondary LBO...
Dynacure’s Merger with Flamingo Therapeutics
McDermott advised Dynacure on its merger. Dynacure, a company that aims to develop and commercialize new therapies to improve the lives of patients with rare diseases...
Apax’s Investment in Porsolt Group
Hogan Lovells advised Apax on the acquisition. McDermott, Will & Emery advised the Prosolt group on the sale. Apax Partners, a prominent European private equity firm,...
Adrian’s Investment in Théradial Group
Mcdermott advised Adrian. De Pardieu Brocas Maffei advised UI Investissement. The management team of the Théradial group led by Frédéric Le Pottier was advised by Fidal....
Luxempart Group’s Acquisition of a Minority Stake in Kestrel Vision
PwC advised Kestrel Vision. Ashurst advised Caravelle. McDermott Will & Emery advised Luxempart. Kestrel Vision, a global leader in glass control and inspection, has begun a...
Innate Pharma’s Expansion of Collaboration with Sanofi
McDermott Will & Emery advised Innate Pharma on the deal. Innate Pharma announced the expansion of its collaboration with Sanofi. Sanofi is licensing a natural killer...